GLAM
STJ

Gardner Lewis Asset Management’s St Jude Medical STJ Stock Holding History

Gardner Lewis Asset Management’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,242,078
Closed -$99.6M – 130
2016
Q4 		$99.6M Buy
1,242,078
+313,859
+34% +$24.9M 7.7% 1
2016
Q3 		$74M Buy
928,219
+502,952
+118% +$40.6M 5.99% 4
2016
Q2 		$33.2M Buy
+425,267
New +$30.3M 3.49% 7

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Gardner Lewis Asset Management's STJ Position: Q1 2017 in Review

Gardner Lewis Asset Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 1,242,078 shares — an estimated $99.6M sold.

Gardner Lewis Asset Management first reported a position in STJ in Q2 2016 and held it in 3 quarters. The position peaked at $99.6M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Gardner Lewis Asset Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 1,242,078 St Jude Medical shares in Q1 2017, an estimated $99.6M.
  • Gardner Lewis Asset Management first reported a position in St Jude Medical in Q2 2016 and held it in 3 quarters.
  • Gardner Lewis Asset Management's St Jude Medical position peaked at $99.6M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Gardner Lewis Asset Management's 13F filing for Q1 2017, filed 15 May 2017.